申请人:Bosch José Aiguade
公开号:US20120225904A1
公开(公告)日:2012-09-06
This disclosure is directed to, inter alis, new inhibitors of the p38 mitogen-activated protein kinase having the general formula (I), to processes for their preparation, to pharmaceutical compositions comprising them, and to their use in therapy.
本公开涉及到的是p38丝裂原活化蛋白激酶的新抑制剂,具有一般式(I),关于它们的制备方法,包含它们的制药组合物以及它们在治疗中的使用。